Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histological and Molecular Profiling in the Diagnostics and Treatment of Small-Bowel Diseases - A Prospective Cohort Study (The DeepBowel Study)

NCT07556328 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT07556328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histological and Molecular Profiling in the Diagnostics and Treatment of Small-Bowel Diseases - A Prospective Cohort Study (The DeepBowel Study)
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2035
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, refractory celiac disease, small bowel disease